The drug contributes to a higher percentage of body-mass weight loss compared to previous weight-loss medications, and accomplishes this more quickly.

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a year, according to a Cleveland Clinic study published Friday.

Ozempic and Wegovy are similar drugs that contain the same active ingredient, semaglutide, though Wegovy contains a higher amount of it and is FDA-approved specifically for weight loss.

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to a preprint study. Researchers found that people prescribed semaglutide ...

Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications ...

In a head-to-head study in the New England Journal of Medicine, people taking Zepbound, Wegovy, Zepbound led to greater weight loss.

Topline Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterparts—but also experienced more nausea ...

Using a random sample of 16 million patients, researchers found that women who newly initiated semaglutide (Ozempic, Wegovy) had a twofold higher risk of hair loss than those starting on the ...